| Literature DB >> 26617228 |
Cevdet Ozdemir1, Umut Can Kucuksezer2, Mübeccel Akdis3, Cezmi A Akdis4.
Abstract
Allergen immunotherapy (AIT) is an effective way to treat allergic disorders, targeting the underlying mechanisms and altering the disease course by inducing a long-lasting clinical and immune tolerance to allergens. Although sublingual and subcutaneous routes are used in daily practice, many novel ways to decrease side effects and duration and increase efficacy have been pursued. Further studies are needed to develop biomarkers for the identification of AIT responder patients and also to use the developed knowledge in allergy prevention studies. Future directions in AIT include treatments for autoimmune diseases, chronic infections, organ transplantation, and breaking immune tolerance to cancer cells.Entities:
Keywords: Allergens; Allergy; Immunotherapy; T regulatory cells; Tolerance
Mesh:
Substances:
Year: 2016 PMID: 26617228 DOI: 10.1016/j.iac.2015.08.003
Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN: 0889-8561 Impact factor: 3.479